(Q50665932)
Statements
Cost-effectiveness of interferon beta-1b in slowing multiple sclerosis disability progression. First estimates. (English)
1 reference
Brown MG
1 reference
Murray TJ
1 reference
Sketris IS
1 reference
Fisk JD
1 reference
LeBlanc JC
1 reference
Schwartz CE
1 reference
1 January 2000
1 reference
16
1 reference
3
1 reference
751-767
1 reference